Correlations between Income Inequality and Antimicrobial Resistance

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kirby, Andrew ^a   Herbert, Annie ^b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b PENNINE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DEVELOPED COUNTRY; DRUG USE; ECONOMIC ASPECT; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EUROPE; INCOME INEQUALITY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIA; DEVELOPED COUNTRIES; DRUG RESISTANCE, MICROBIAL; EUROPE; HUMANS; PUBLIC HEALTH SURVEILLANCE; SOCIOECONOMIC FACTORS;

EID: 84883217791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073115     Document Type: Article

References (34)

1. Rice LB, (2009) The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 12: 476-481. doi:10.1016/j.mib.2009.08.001. PubMed: 19716760.
2. ECDC/EMEA (2009) The bacterial challenge: time to react, Joint Technical Report from ECDC and EMA. Stockholm, Sweden: European Centre for Disease Prevention and Control.
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M, (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579-587. doi:10.1016/S0140-6736(05)70799-6. PubMed: 15708101.
4. Farmer P, (1996) Social inequalities and emerging infectious diseases. Emerg Infect Dis 2: 259-269. doi:10.3201/eid0204.960402. PubMed: 8969243.
5. Wilkinson RG, Pickett KE, (2007) The problems of relative deprivation: why some societies do better than others. Soc Sci Med 65: 1965-1978. doi:10.1016/j.socscimed.2007.05.041. PubMed: 17618718.
6. Solt F, (2009) Standardizing the World Income Inequality Database. Soc Sci Q 90: 231-242. doi:10.1111/j.1540-6237.2009.00614.x.
7. The European Antimicrobial Resistance Surveillance System (2009) EARSS Annual Report 2008, Bilthoven, The Netherlands.
8. Adriaenssens N, Coenen S, Versporten A, Muller A, Vankerckhoven V, et al. (2011) European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 66 (Suppl 6):: 71-77. doi:10.1093/jac/dkr129. PubMed: 22096068.
9. WHO (2004) The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). Norway.
10. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, et al. (2011) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 66 (Suppl 6):: 3-12. doi:10.1093/jac/dkr119. PubMed: 22096064.
11. Hunter JE, Schmidt FL, (1990) Methods of Meta-analysis: correcting error and bias in research findings. Newbury Park, California; London; New Delhi: SAGE.
12. Zou KH, Tuncali K, Silverman SG, (2003) Correlation and simple linear regression. Radiology 227: 617-622. doi:10.1148/radiol.2273011499. PubMed: 12773666.
13. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H, et al. (2006) Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 58: 159-167. doi:10.1093/jac/dkl147. PubMed: 16698845.
14. Paterson DL, (2006) Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 34 (Suppl 1):: 20-28. doi:10.1016/j.ajic.2006.05.175.
15. Roberts AD, Simon GL, (2012) Diabetic foot infections: the role of microbiology and antibiotic treatment. Semin Vasc Surg 25: 75-81. doi:10.1053/j.semvascsurg.2012.04.010. PubMed: 22817856.
16. Semins MJ, Shore AD, Makary MA, Weiner J, Matlaga BR, (2012) The impact of obesity on urinary tract infection risk. Urology 79: 266-269. doi:10.1016/j.urology.2011.09.040. PubMed: 22130358.
17. Butler CC, Hood K, Verheij T, Little P, Melbye H, et al. (2009) Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 338: b2242. doi:10.1136/bmj.b2242. PubMed: 19549995.
18. Filippini M, Masiero G, Moschetti K, (2006) Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 78: 77-92. doi:10.1016/j.healthpol.2005.09.009. PubMed: 16290129.
19. Singh R, Tam VH, (2011) Optimizing dosage to prevent emergence of resistance- lessons from in vitro models. Curr Opin Pharmacol 11: 453-456. doi:10.1016/j.coph.2011.07.009. PubMed: 21868287.
20. Rea RS, Capitano B, Bies R, Bigos KL, Smith R, et al. (2008) Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit 30: 674-681. doi:10.1097/FTD.0b013e31818b6b2f. PubMed: 19057371.
21. David MZ, Daum RS, (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23: 616-687. doi:10.1128/CMR.00081-09. PubMed: 20610826.
22. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, et al. (2005) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 60: 130-135. doi:10.1136/thx.2004.026922. PubMed: 15681501.
23. Livermore DM, (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: 557-584. PubMed: 8665470.
24. Marothi YA, Agnihotri H, Dubey D, (2005) Enterococcal resistance--an overview. Indian J Med Microbiol 23: 214-219. PubMed: 16327115.
25. Liñares J, Ardanuy C, Pallares R, Fenoll A, (2010) Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 16: 402-410. doi:10.1111/j.1469-0691.2010.03182.x. PubMed: 20132251.
26. Raphael D, (2011) Poverty in childhood and adverse health outcomes in adulthood. Maturitas 69: 22-26. doi:10.1016/j.maturitas.2011.02.011. PubMed: 21398059.
27. Subramanian SV, Kawachi I, (2006) Whose health is affected by income inequality? A multilevel interaction analysis of contemporaneous and lagged effects of state income inequality on individual self-rated health in the United States. Health Place 12: 141-156. doi:10.1016/j.healthplace.2004.11.001. PubMed: 16338630.
28. Chen FM, Breiman RF, Farley M, Plikaytis B, Deaver K, et al. (1998) Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol 148: 1212-1218. doi:10.1093/oxfordjournals.aje.a009611. PubMed: 9867268.
29. Nilsson P, Laurell MH, (2005) Impact of socioeconomic factors and antibiotic prescribing on penicillin- non-susceptible Streptococcus pneumoniae in the city of Malmö. Scand J Infect Dis 37: 436-441. doi:10.1080/00365540510037795. PubMed: 16012003.
30. Murphy M, Byrne S, Bradley CP, (2011) Influence of patient payment on antibiotic prescribing in Irish general practice: a cohort study. Br J Gen Pract 61: e549-e555. doi:10.3399/bjgp11X593785. PubMed: 22152734.
31. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL, (2011) Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 53: 49-56. doi:10.1093/cid/cir273. PubMed: 21653302.
32. Hulscher ME, Grol RP, van der Meer JW, (2010) Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 10: 167-175. doi:10.1016/S1473-3099(10)70027-X. PubMed: 20185095.
33. Harada K, Asai T, (2010) Role of antimicrobial selective pressure and secondary factors on antimicrobial resistance prevalence in Escherichia coli from food-producing animals in Japan. J Biomed Biotechnol, 2010(2010): 180682. PubMed: 20589071.
34. UK Department of Health (2010) Liberating the NHS: Legislative framework and next steps. UK: London.